ZIM
INO icon

Zacks Investment Management’s Inovio Pharmaceuticals INO Stock Holding History

Zacks Investment Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,455
Closed -$45.5K – 780
2025
Q3 		$45.5K Buy
+19,455
New +$37.3K ﹤0.01% 733
2019
Q4 		– Sell
-2,866
Closed -$71K – 560
2019
Q3 		$71K Buy
+2,866
New +$87.1K ﹤0.01% 509
2017
Q4 		– Sell
-1,806
Closed -$137K – 608
2017
Q3 		$137K Buy
+1,806
New +$134K ﹤0.01% 558

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Zacks Investment Management's INO Position: Q4 2025 in Review

Zacks Investment Management sold out of Inovio Pharmaceuticals (INO) in Q4 2025, closing a stake of 19,455 shares — an estimated $45.5K sold.

Zacks Investment Management first reported a position in INO in Q3 2017 and held it in 3 quarters. The position peaked at $137K in Q3 2017. 102 funds tracked by Wall St. Rank hold INO as of Q4 2025.

  • Zacks Investment Management reported no remaining Inovio Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Zacks Investment Management sold 19,455 Inovio Pharmaceuticals shares in Q4 2025, an estimated $45.5K.
  • Zacks Investment Management first reported a position in Inovio Pharmaceuticals in Q3 2017 and held it in 3 quarters.
  • Zacks Investment Management's Inovio Pharmaceuticals position peaked at $137K in Q3 2017.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2025.

Based on Zacks Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.